All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Fri 2025-05-16 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
+11.89%
2025-05-16 |
17.32 TRR
2025-05-16 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-05-16 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,632.17%
+7.29%/yr |
+5.19%/yr
(R2=0.681) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-05-16 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$173,216.75
2025-05-16 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | +11.89% |
2024 | −7.76% |
2023 | +6.14% |
2022 | −23.24% |
2021 | +18.35% |
2020 | −18.89% |
2019 | +26.23% |
2018 | +11.57% |
2017 | −5.07% |
2016 | −0.06% |
2015 | −1.08% |
2014 | −16.40% |
2013 | +26.88% |
2012 | −1.16% |
2011 | +18.99% |
2010 | −3.68% |
2009 | +16.09% |
2008 | −22.42% |
2007 | −4.73% |
2006 | +5.23% |
2005 | +6.21% |
2004 | +2.24% |
2003 | +26.37% |
2002 | −23.45% |
2001 | −11.01% |
2000 | +0.67% |
1999 | −20.09% |
1998 | +45.77% |
1997 | +53.18% |
1996 | +14.01% |
1995 | +41.58% |
1994 | +0.33% |
1993 | −12.89% |
1992 | −25.14% |
1991 | +92.97% |
1990 | +22.85% |
1989 | +32.49% |
1988 | +2.46% |
1987 | +15.34% |
1986 | +37.63% |
1985 | +68.47% |
1984 | −1.93% |
Mon 1984-11-05? to Fri 2025-05-16 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −20.62% |
−60.49%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||